Literature DB >> 17043295

Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke.

A Chamorro1, S Amaro, M Vargas, V Obach, A Cervera, F Torres, A M Planas.   

Abstract

BACKGROUND AND
PURPOSE: The pathophysiology of stroke-associated infection (SAI) is uncertain. The cytokine profile and peripheral white cell response were assessed in patients with or without SAI.
METHODS: The incidence of SAI was assessed in 110 patients with ischaemic stroke allocated antibiotic prophylaxis or placebo within 24 h of clinical onset. Peripheral white cell counts, interleukin (IL)6, tumour necrosis factor (TNF)alpha and IL10 were measured in plasma.
RESULTS: 17 (15%) patients developed infection and showed time-dependent increases of total white cell count, neutrophils, monocytes, lymphocytes, IL6 and IL10, whereas TNFalpha and the TNFalpha/IL10 ratio decreased. In logistic regression, IL10 (odds ratio (OR) 1.08, 95% confidence interval (CI) 1.01 to 1.16), monocyte count (OR 1.42, 95% CI 1.08 to 1.87) and National Institute for Health Stroke Survey score on admission (OR 1.17, 95% CI 1.05 to 1.31) were independent predictors of systemic infection.
CONCLUSIONS: SAI is associated with stroke severity, excessive IL10-mediated response and an increased number of circulating monocytes. These results support the finding that acute ischaemic brain injury triggers a blood-borne anti-inflammatory response that decreases the antimicrobial drive of the immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043295      PMCID: PMC2077369          DOI: 10.1136/jnnp.2006.100800

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial.

Authors:  A Chamorro; J P Horcajada; V Obach; M Vargas; M Revilla; F Torres; A Cervera; A M Planas; J Mensa
Journal:  Stroke       Date:  2005-06-16       Impact factor: 7.914

2.  IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.

Authors:  A M O'Farrell; Y Liu; K W Moore; A L Mui
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 3.  Mechanisms of interleukin-10-mediated immune suppression.

Authors:  C A Akdis; K Blaser
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

4.  Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.

Authors:  Nicolás Vila; José Castillo; Antonio Dávalos; Anna Esteve; Anna M Planas; Angel Chamorro
Journal:  Stroke       Date:  2003-02-20       Impact factor: 7.914

Review 5.  Acquired immunologic deficiencies after trauma and surgical procedures.

Authors:  R J Howard; R L Simmons
Journal:  Surg Gynecol Obstet       Date:  1974-11

6.  Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators.

Authors:  K C Johnston; J Y Li; P D Lyden; S K Hanson; T E Feasby; R J Adams; R E Faught; E C Haley
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

7.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.

Authors:  H Besedovsky; A del Rey; E Sorkin; C A Dinarello
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

8.  Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials?

Authors:  Martha Vargas; Juan P Horcajada; Victor Obach; Marina Revilla; Alvaro Cervera; Ferrán Torres; Anna M Planas; Josep Mensa; Angel Chamorro
Journal:  Stroke       Date:  2005-12-29       Impact factor: 7.914

9.  Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine.

Authors:  Ruediger Hilker; Carsten Poetter; Nahide Findeisen; Jan Sobesky; Andreas Jacobs; Michael Neveling; Wolf-Dieter Heiss
Journal:  Stroke       Date:  2003-03-13       Impact factor: 7.914

10.  Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Authors:  Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more
  41 in total

Review 1.  The immunology of acute stroke.

Authors:  Ángel Chamorro; Andreas Meisel; Anna M Planas; Xabier Urra; Diederik van de Beek; Roland Veltkamp
Journal:  Nat Rev Neurol       Date:  2012-06-05       Impact factor: 42.937

Review 2.  Regulatory B cells in experimental stroke.

Authors:  Hilary A Seifert; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2018-02-05       Impact factor: 7.397

3.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

4.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

5.  Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study.

Authors:  Amelia K Boehme; Purnima Ranawat; Jorge Luna; Hooman Kamel; Mitchell S V Elkind
Journal:  Stroke       Date:  2017-02-14       Impact factor: 7.914

6.  Remote Postischemic Conditioning Promotes Stroke Recovery by Shifting Circulating Monocytes to CCR2+ Proinflammatory Subset.

Authors:  Jiwon Yang; Mustafa Balkaya; Cesar Beltran; Ji Hoe Heo; Sunghee Cho
Journal:  J Neurosci       Date:  2019-08-19       Impact factor: 6.167

Review 7.  Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets.

Authors:  Danielle N Doll; Taura L Barr; James W Simpkins
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

Review 8.  The three human monocyte subsets: implications for health and disease.

Authors:  Kok Loon Wong; Wei Hseun Yeap; June Jing Yi Tai; Siew Min Ong; Truong Minh Dang; Siew Cheng Wong
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

9.  Activation of immune responses to brain antigens after stroke.

Authors:  Kyra J Becker
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

10.  Leukocyte recruitment and ischemic brain injury.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neuromolecular Med       Date:  2009-07-05       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.